Lluc has earned a Cum Laude PhD in Biomedicine from Pompeu Fabra University, marking a significant milestone for both himself and Flomics. As Flomics’ first PhD student and original team member, Lluc’s achievement is a testament to our company’s dedication to fostering academic excellence. In his recently defended thesis titled “Analysis of circulating RNAs for the early detection of complex diseases using liquid biopsy,” Lluc has delved deep into Flomics’ core research mission. After months of diligent work, he has unearthed compelling insights and charted promising paths for further investigation. Notable among his findings are:
- Plasma circulating miRNAs can be used to differentiate cerebral atrophy patients (PMM2-CDG) from controls.
- The origin of biomarkers related to cerebellar atrophies may stem from tissues elsewhere in the body, independent of the brain.
- A liver-specific miRNA is especially relevant for the detection of PMM2-CDG patients.
- The absence of standardized protocols for sample collection and processing hinders the viability of the cfRNA projects
- DNAse treatment is the most important step in plasma-based cfRNA. Our DNAse treatment combination has been shown to eliminate the majority of the DNA contamination in plasma samples.
Lluc’s thesis has been honored with a Cum Laude distinction, and we couldn’t be prouder of this achievement!